CNCE

Concert Pharmaceuticals, Inc.

Delisted

CNCE was delisted on the 3rd of March, 2023.

87 hedge funds and large institutions have $202M invested in Concert Pharmaceuticals, Inc. in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 21 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
87
Holders Change
-5
Holders Change %
-5.43%
% of All Funds
1.89%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
20
Increased
35
Reduced
21
Closed
23
Calls
$3.21M
Puts
$2.92M
Net Calls
+$293K
Net Calls Change
-$714K
Name Holding Trade Value Shares
Change
Shares
Change %
Canada Life
101
Canada Life
Manitoba, Canada
-$47K -3,949 Closed
Zurich Cantonal Bank
102
Zurich Cantonal Bank
Switzerland
-$17K -1,415 Closed
Twin Tree Management
103
Twin Tree Management
Texas
-$8K -641 Closed
WAM
104
Wealthspire Advisors (Maryland)
Maryland
-$4K -300 Closed
TRCT
105
Tower Research Capital (TRC)
New York
-$3K -288 Closed
CG
106
Cutler Group
California
-$2K -200 Closed
AIC
107
Ameritas Investment Company
Nebraska
-$1K -97 Closed